Is Adjunctive Hyperbaric Oxygen Treatment Alone or with Surgery the Proper Management for Active and Persistent

Kamonwan Jenwitheesuk1, Ajanee Mahakkanukrauh, Wiyada Punjaruk

  • 1At Khon Kaen University, Khon Kaen, Thailand, Kamonwan Jenwitheesuk, MD, is Associate Professor, Plastic & Reconstructive Unit, Department of Surgery, Faculty of Medicine; Ajanee Mahakkanukrauh, MD, is Associate Professor, Division of Allergy-Immunology-Rheumatology, Faculty of Medicine; Wiyada Punjaruk, MD, PhD, is Assistant Professor, Department of Physiology, Faculty of Medicine; Patravoot Vatanasapt, MD, is Assistant Professor, Head & Neck Surgery Unit, Department of Otorhinolaryngology, Faculty of Medicine; Kriangsak Jenwitheesuk, MD, is Associate Professor, General Surgery Unit, Department of Surgery, Faculty of Medicine; Palakorn Surakunprapha, MD, is Assistant Professor, Plastic & Reconstructive Unit, Department of Surgery, Faculty of Medicine; Suthin Jinaporntham, MD, DDS, is Assistant Professor, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry; Krittinant Uraiwan, DDS, is Maxillofacial Surgeon, Dental Department, Srinagarind Hospital, Faculty of Medicine; and Phasuk Limrattanapimpa, MNS, is Nurse Specialist, Hyperbaric Oxygen Therapy Unit, Srinagarind Hospital, Faculty of Medicine. Acknowledgments: The authors thank University of Wisconsin Professor Emeritus James A. Will for assistance with the English language presentation of the manuscript under the aegis of the Publication Clinic, Research Affairs, Faculty of Medicine, KKU. This study was funded by a grant from Khon Kaen University, Faculty of Medicine (no. MN61203). The authors have disclosed no other financial relationships related to this article. Submitted January 15, 2020; accepted in revised form March 4, 2020.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
434
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
135
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
117
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
325
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
238
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
612